Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Optinose Inc
(NQ:
OPTN
)
1.110
-0.020 (-1.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Optinose Inc
< Previous
1
2
3
4
5
Next >
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
December 06, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
November 22, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
November 09, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Recap: OptiNose Q1 Earnings
May 11, 2023
Via
Benzinga
OptiNose's Return On Capital Employed Insights
March 09, 2023
Via
Benzinga
Earnings Preview: OptiNose
March 06, 2023
Via
Benzinga
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
October 27, 2023
Conference Call and Webcast to be held November 9, 2023, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the 2023 Cantor Global Healthcare Conference
September 22, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
August 21, 2023
Via
Benzinga
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
August 10, 2023
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 28, 2023
Via
Benzinga
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
July 27, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 07, 2023
On Wednesday, 29 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 06, 2023
On Tuesday, 69 stocks hit new 52-week lows.
Via
Benzinga
Optinose to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
May 19, 2023
On Friday, 63 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 19, 2023
Via
Benzinga
Optinose Reports First Quarter 2023 Financial Results and Operational Updates
May 11, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE
May 04, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for First Quarter 2023 Financial Results
May 01, 2023
Conference Call and Webcast to be held May 11, 2023, at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 18, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the Needham Virtual Healthcare Conference
April 12, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights
March 07, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results
February 28, 2023
Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion
February 21, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces CEO Transition and Business Update
January 31, 2023
Ramy Mahmoud, MD, MPH appointed CEO and to the Board of Directors
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Appoints Paul Spence as Chief Commercial Officer
December 15, 2022
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Departure of Acting Chief Financial Officer
December 09, 2022
From
Optinose, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.